Skip to main content
. 2017 Dec 15;114(50):866–873. doi: 10.3238/arztebl.2017.0866

Table 3. Long-term antibiotic prophylaxis of recurring urinary tract infection (after [31]).

Substance Dosage Anticipated UTI rate per
patient year
Sensitivity Collateral
damage
Safety/adverse drug
reactions (ADR)
Continuous long-term prophylaxis
Cotrimoxazole 40/200 mg 1 × daily 0–0.2 +(+) ++ ++
Cotrimoxazole 40/200 mg 3 × weekly 0.1 +(+) ++ ++
Trimethoprim 100 mg 1 × daily*1 0–1.5 +(+) ++ +++
Nitrofurantoin 50 mg 1 × daily 0–0.6 +++ +++ ++
Nitrofurantoin 100 mg 1 × daily*2 0–0.7 +++ +++ ++
Cefaclor 250 mg 1 × daily*3 0.0 n.d. + +++
Cefaclor 125 mg 1 × daily*3 0.1 n.d. + +++
Norfloxacin 200 mg 1 × daily*3 0.0 ++ + ++
Ciprofloxacin 125 mg 1 × daily*3 0.0 ++ + ++
Fosfomycin- trometamol 3 g every 10 days 0.14 +++ +++ +++
Postcoital single-dose prophylaxis
Cotrimoxazole 40/200 mg 0.3 +(+) ++ ++
Cotrimoxazole 80/400 mg 0.0 +(+) ++ ++
Nitrofurantoin 50 mg 0.1 +++ +++ ++
Nitrofurantoin 100 mg*2 0.1 +++ +++ ++
Cefalexin 250 mg*3 0.0 n.d. + +++
Cefalexin 125 mg*3 0.0 n.d. + +++
Norfloxacin 200 mg*3 0.0 ++ + ++
Ofloxacin 100 mg*3 0.03 ++ + ++

*1In older studies, trimethoprim 50 mg was reported as equieffective to 100 mg; *2in the case of equieffectiveness, nitrofurantoin 50 mg is the dose of choice; *3to avoid collateral damage and above all increasing resistance; use only if the other substances cannot be used.

n.d., No data

Symbols as explained in Table 1